Dengue fever, caused by the dengue virus, is a significant public health issue in many tropical and subtropical regions worldwide. This blog post will delve into the causes, symptoms, prevention, and treatment of dengue fever, with a focus on essential aspects such as the dengue virus, dengue test, dengue vaccine, dengue platelet count, and the duration of the illness.
For More details : https://blog.simpleekare.com/dengue-fever-causes-symptoms-prevention-treatment/
Dengue fever- a medical study ( definition, management ,prevention ,risks ,pa...martinshaji
#Dengue fever is a mosquito-borne disease that occurs in #tropical and #subtropical areas of the #world. Mild dengue fever causes high fever, #rash, and #muscle and #joint pain. A severe form of dengue #fever, also called dengue #hemorrhagic fever, can cause severe #bleeding, a sudden drop in #blood pressure (#shock) and #death.
#Millions of cases of dengue infection occur #worldwide each year. Dengue fever is most common in #Southeast #Asia and the #western #Pacific #islands, but the #disease has been increasing rapidly in #Latin #America and the #Caribbean
please comment
thank you
Dengue & Chikungunya - All You Need To Know!Akshit Arora
A presentation on Dengue & Chikungunya and preventive measures! Received via one Instant Messenger application. Don't know about the credibility whether it's actually from the WHO or not! But good enough for education.
Dengue (pronounced DENG-gay) can affect anyone but tends to be more severe in people with compromised immune systems. Because it is caused by one of four serotypes of virus, it is possible to get dengue fever multiple times. However, an attack of dengue produces immunity for a lifetime to that particular serotype to which the patient was exposed.
Dengue fever- a medical study ( definition, management ,prevention ,risks ,pa...martinshaji
#Dengue fever is a mosquito-borne disease that occurs in #tropical and #subtropical areas of the #world. Mild dengue fever causes high fever, #rash, and #muscle and #joint pain. A severe form of dengue #fever, also called dengue #hemorrhagic fever, can cause severe #bleeding, a sudden drop in #blood pressure (#shock) and #death.
#Millions of cases of dengue infection occur #worldwide each year. Dengue fever is most common in #Southeast #Asia and the #western #Pacific #islands, but the #disease has been increasing rapidly in #Latin #America and the #Caribbean
please comment
thank you
Dengue & Chikungunya - All You Need To Know!Akshit Arora
A presentation on Dengue & Chikungunya and preventive measures! Received via one Instant Messenger application. Don't know about the credibility whether it's actually from the WHO or not! But good enough for education.
Dengue (pronounced DENG-gay) can affect anyone but tends to be more severe in people with compromised immune systems. Because it is caused by one of four serotypes of virus, it is possible to get dengue fever multiple times. However, an attack of dengue produces immunity for a lifetime to that particular serotype to which the patient was exposed.
Rainbow Hospital is the No. 1 super specialty hospital offering the best NICU care in Hyderabad, a state-of-the-art neonatal care, rated as best intensive units for children and neonatal intensive care unit.
One of the most common mosquito-borne illnesses that is prevalent across many parts of the world is dengue. As of now, there is no vaccination for dengue fever and the only way to prevent infection is taking all the necessary precautions. These include wearing full-bodied clothes to prevent mosquito bites, using an effective mosquito repellant and not letting water gather in or around the place where you reside.
Dengue fever is transmitted by the bite of an Aedes mosquito infected with a dengue virus. The mosquito becomes infected when it bites a person with dengue virus in their blood. It can’t be spread directly from one person to another person.In this file you will get to know the signs, symptoms, treatments and prevention technque on the dengue fever. This kind of illness and disease can be treated and cured significantly
Dengue fever is the fastest emerging arboviral infection spread
by Aedes mosquitoes with major public health consequences in
over 100 tropical and sub-tropical countries in South-East Asia,
the Western Pacific, and South and Central America. Up to 2.5
billion people globally live under the threat of dengue fever and its
severe forms—dengue hemorrhagic fever (DHF) or dengue shock
syndrome (DSS). More than 75% of these people, or approximately
1.8 billion, live in the Asia-Pacific Region. As the disease spreads to
new geographical areas, the frequency of the outbreaks is increasing
along with changing disease epidemiology. It is estimated that 50
a million cases of dengue fever occur worldwide annually and half a
million people suffering from DHF require hospitalization each year,
a very large proportion of whom (approximately 90%) are children
less than five years old. About 2.5% of those affected with dengue
die of the disease.
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
More Related Content
Similar to Dengue Fever_ Causes, Symptoms, Prevention & Treatment.pdf
Rainbow Hospital is the No. 1 super specialty hospital offering the best NICU care in Hyderabad, a state-of-the-art neonatal care, rated as best intensive units for children and neonatal intensive care unit.
One of the most common mosquito-borne illnesses that is prevalent across many parts of the world is dengue. As of now, there is no vaccination for dengue fever and the only way to prevent infection is taking all the necessary precautions. These include wearing full-bodied clothes to prevent mosquito bites, using an effective mosquito repellant and not letting water gather in or around the place where you reside.
Dengue fever is transmitted by the bite of an Aedes mosquito infected with a dengue virus. The mosquito becomes infected when it bites a person with dengue virus in their blood. It can’t be spread directly from one person to another person.In this file you will get to know the signs, symptoms, treatments and prevention technque on the dengue fever. This kind of illness and disease can be treated and cured significantly
Dengue fever is the fastest emerging arboviral infection spread
by Aedes mosquitoes with major public health consequences in
over 100 tropical and sub-tropical countries in South-East Asia,
the Western Pacific, and South and Central America. Up to 2.5
billion people globally live under the threat of dengue fever and its
severe forms—dengue hemorrhagic fever (DHF) or dengue shock
syndrome (DSS). More than 75% of these people, or approximately
1.8 billion, live in the Asia-Pacific Region. As the disease spreads to
new geographical areas, the frequency of the outbreaks is increasing
along with changing disease epidemiology. It is estimated that 50
a million cases of dengue fever occur worldwide annually and half a
million people suffering from DHF require hospitalization each year,
a very large proportion of whom (approximately 90%) are children
less than five years old. About 2.5% of those affected with dengue
die of the disease.
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
Telehealth Psychology Building Trust with Clients.pptxThe Harvest Clinic
Telehealth psychology is a digital approach that offers psychological services and mental health care to clients remotely, using technologies like video conferencing, phone calls, text messaging, and mobile apps for communication.
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptxR3 Stem Cell
R3 Stem Cells and Kidney Repair: A New Horizon in Nephrology" explores groundbreaking advancements in the use of R3 stem cells for kidney disease treatment. This insightful piece delves into the potential of these cells to regenerate damaged kidney tissue, offering new hope for patients and reshaping the future of nephrology.
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfSachin Sharma
This content provides an overview of preventive pediatrics. It defines preventive pediatrics as preventing disease and promoting children's physical, mental, and social well-being to achieve positive health. It discusses antenatal, postnatal, and social preventive pediatrics. It also covers various child health programs like immunization, breastfeeding, ICDS, and the roles of organizations like WHO, UNICEF, and nurses in preventive pediatrics.
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)
We understand the unique challenges pickleball players face and are committed to helping you stay healthy and active. In this presentation, we’ll explore the three most common pickleball injuries and provide strategies for prevention and treatment.
1. Dengue fever, caused by the dengue virus, is a significant public health issue in many tropical
and subtropical regions worldwide. This blog post will delve into the causes, symptoms,
prevention, and treatment of dengue fever, with a focus on essential aspects such as the
dengue virus, dengue test, dengue vaccine, dengue platelet count, and the duration of the
illness.v
Causes of Dengue Fever
The dengue virus is primarily transmitted to humans through the bite of infected Aedes
mosquitoes, particularly Aedes aegypti and Aedes albopictus. These mosquitoes are commonly
found in urban and semi-urban areas and are most active during the day, with peak biting times
in the early morning and late afternoon. The virus can also be transmitted through blood
transfusions and from an infected mother to her baby during childbirth.
Symptoms of Dengue Fever
Following an incubation period of 4 to 7 days after being bitten by an infected mosquito,
symptoms of dengue fever typically manifest. The most common symptoms include:
1. High Fever: Sudden onset of high-grade fever, often reaching 104°F (40°C) or higher.
2. Severe Headache: Intense headaches, primarily located behind the eyes.
3. Joint and Muscle Pain: Severe joint and muscle pain, often described as aching or bone-
breaking pain.
4. Rash: A maculopapular rash that appears two to five days after the onset of fever.
5. Fatigue: Generalized weakness, fatigue, and malaise.
6. Mild Bleeding: Some individuals may experience mild bleeding from the nose or gums,
as well as easy bruising.
In severe cases, dengue can progress to dengue hemorrhagic fever (DHF) or dengue shock
syndrome (DSS). Warning signs of severe dengue include severe abdominal pain, persistent
vomiting, bleeding gums, difficulty breathing, restlessness, and blood in vomit or stools. These
severe forms of dengue can be life-threatening and require immediate medical attention.
Diagnosis and Dengue Test
Dengue Fever: Causes, Symptoms, Prevention & Treatment
2. Healthcare professionals employ various diagnostic methods to confirm dengue fever. One
common approach involves dengue tests, which typically include blood tests to detect the
presence of the dengue virus or antibodies produced in response to the infection.
The NS1 antigen test detects the presence of a viral protein called NS1 antigen in the blood. It
is most effective during the early stages of infection when the virus is actively replicating. The
dengue antibody test, also known as serology, checks for the presence of antibodies (IgM and
IgG) against the dengue virus. IgM antibodies are typically detectable during the acute phase,
while IgG antibodies indicate past infection or vaccination.
Prevention of Dengue Fever
Preventing dengue fever involves both individual and community-based measures to reduce
mosquito populations and minimize exposure to mosquito bites. Key preventive measures
include:
1. Eliminating Mosquito Breeding Sites: Removing standing water from containers, flower
pots, discarded tires, and other objects that can collect water, as mosquitoes breed in
stagnant water.
2. Mosquito Repellents: Using insect repellents containing DEET, picaridin, or oil of lemon
eucalyptus on exposed skin.
3. Protective Clothing: Wearing long sleeves, long pants, and socks to minimize exposed
skin areas.
4. Window Screens and Bed Nets: Installing window screens and using bed nets,
especially during sleep hours, to prevent mosquitoes from entering living areas.
5. Community-Wide Mosquito Control: Implementing community efforts such as larviciding
(treating water sources with larvicides to kill mosquito larvae) and insecticide spraying to
control mosquito populations.
Dengue Vaccine and Treatment
Currently, the only licensed dengue vaccine is Dengvaxia. It is recommended for individuals
aged 9 to 45 years living in areas with high dengue transmission rates. The vaccine provides
partial protection against dengue and can help reduce the severity of the disease in vaccinated
individuals. However, it is essential to note that the vaccine is not effective against all four
dengue serotypes and may not be universally available.
There is no specific antiviral treatment for dengue fever. Medical care primarily focuses on
relieving symptoms and providing supportive care. It is crucial to stay well-hydrated by drinking
plenty of fluids, especially oral rehydration solutions. Managing fever and pain with appropriate
medications, such as acetaminophen (paracetamol), is also recommended. However, non-
steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen and aspirin should be avoided, as
they can increase the risk of bleeding.
3. In severe cases, hospitalization may be required, particularly for individuals with dengue
hemorrhagic fever or dengue shock syndrome. Close monitoring of the dengue platelet count is
crucial, as a significant drop in platelets may indicate a severe form of the disease and the need
for immediate medical intervention.
Duration of Dengue Fever and Repeat Infections
The duration of dengue fever can vary from person to person. Generally, the acute phase of the
illness lasts for about 2 to 7 days. During this period, individuals experience symptoms such as
high fever, body aches, and rash. After the acute phase, the recovery phase begins, during
which the fever subsides, but weakness and fatigue may persist for several weeks.
It is possible to get dengue fever multiple times. However, subsequent infections with different
dengue serotypes can potentially increase the risk of severe dengue, especially if the individual
had prior immunity to a different serotype.
This is due to a phenomenon called antibody-dependent enhancement, where antibodies from a
previous infection can facilitate the entry of a different dengue serotype into cells, leading to
more severe disease manifestations. Therefore, individuals who have had dengue in the past
should take precautions to avoid further mosquito bites to minimize the risk of subsequent
infections.
SimpleeKare Health
N2, 19 IRC Village Nayapalli
Bhubaneswar